MarketPeel
Insider Trading Intelligence
Pricing
…
RL

Ryan Lynch

CBIO
SEE REMARKS · CRESCENT BIOPHARMA, INC. · CIK 0001709271
FILING MIX · LIFETIME75%/25%
BUYS
3
SELLS
1
TOTAL VALUE
$8.4K
COMPANIES
1
ACTIVE SINCE
Dec 2025
HOLDINGS NOW
13,871
AVG SELL PX
$17.99
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for Ryan Lynch. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
CBIO · 13,871 shares · as of Jun 22, 2026
08,37816,75625,13433,5122026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2025
2026
2026
FLOW · 3 buys / 1 sellsCOVERAGE · 3 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
CBIO
CRESCENT BIOPHARMA, INC.
SALE10b5-1
10b5-1 plan
465$17.99$8.4K13,871Jun 22, 2026Jun 23, 2026 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
4,000——12,378Dec 15, 2025Dec 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
33,512——33,512Dec 15, 2025Dec 17, 2025 ↗View →
CBIO
CRESCENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
8,378——8,378Dec 15, 2025Dec 17, 2025 ↗View →
Other insiders · CBIO
Loading peer insiders…
About this filer
CIK 0001709271
ROLE
See Remarks
PRIMARY
CBIO
COMPANIES
1
ACTIVE SINCE
Dec 2025
MARKETPEEL · /INSIDER/0001709271DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback